The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
复制标题
C反应蛋白/白蛋白比预测晚期胰腺癌患者的总生存率。
DOI:
10.1007/s13277-016-5122-y
复制
发表时间:
2016-09
期刊:
影响因子:
--
通讯作者:
Zuo, Qiang
中科院分区:
文献类型:
--
作者:
Wu, Mengwan;Guo, Jing;Guo, Lihong;Zuo, Qiang
Recent studies have demonstrated the prognostic value of the C-reactive protein/albumin (CRP/Alb) ratio in cancer. However, the role of the CRP/Alb ratio in advanced pancreatic cancer (PC) has not been examined. A retrospective study of 233 patients with advanced PC was conducted. We investigated the relationship between the CRP/Alb ratio, clinicopathological variables, and overall survival (OS). The optimal cutoff point of the CRP/Alb ratio was 0.54. A higher CRP/Alb ratio was significantly associated with an elevated neutrophil-lymphocyte ratio (NLR) (P < 0.001) and higher modified Glasgow prognostic score (mGPS) (P < 0.001). Using univariate analyses, we found that the age (P = 0.009), disease stage (P < 0.001), NLR (P < 0.001), mGPS (P < 0.001), and CRP/Alb ratio (P < 0.001) were significant predictors of OS. Patients with a higher CRP/Alb ratio had a worse OS than patients with a lower CRP/Alb ratio (hazard ratio (HR) 3.619; 95 % CI 2.681–4.886; P < 0.001). However, the CRP/Alb ratio was identified as the only inflammation-based parameter with an independent prognostic ability in the multivariate analyses (P < 0.001). The pretreatment CRP/Alb ratio is a superior prognostic and therapeutic predictor of OS in advanced PC.
登录
查看更多内容
影响因子:
3.7
作者:
Kinoshita, Akiyoshi;Onoda, Hiroshi;Matsushima, Masato
通讯作者:
Matsushima, Masato
影响因子:
8.8
作者:
通讯作者:
--
影响因子:
5
作者:
Liu X;Sun X;Liu J;Kong P;Chen S;Zhan Y;Xu D
通讯作者:
Xu D
影响因子:
254.7
作者:
Torre, Lindsey A.;Bray, Freddie;Jemal, Ahmedin
通讯作者:
Jemal, Ahmedin
影响因子:
2.6
作者:
Garcea, G.;Ladwa, N.;Berry, D. P.
通讯作者:
Berry, D. P.